News and Publications

Coventry & Birmingham, UK – 11 Feb 2026 – Histofy, a leading UK-based pathology AI company, is pleased to announce that it has signed a contract with the West...

Coventry, UK and Vista, CA (6th September 2025) – Histofy, a leading innovator in AI-powered pathology, today announced a customer-centric collaboration with Leica Biosystems, a global leader in anatomic...

Histofy has been certified to ISO/IEC 27001 and ISO 13485, marking a major milestone in its commitment to excellence. The company now meets globally recognised standards for information security...

Histofy and Fundación MD Anderson Cancer Center España announce exclusive partnership to advance AI-driven cancer diagnostics with support of Smart In Media Coventry, UK and Madrid, Spain  (4th June...

Histofy and Source BioScience Announce Strategic Partnership to Advance AI-Powered Pathology in the UK. Coventry & Nottingham, UK (6 May 2025) — Histofy, a leading UK based pathology AI...

Cancer Research Horizons non-exclusively licenses multi-modal S:CORT dataset to enable Histofy to develop AI-based digital pathology tools that stratify colorectal cancer patients based on risk and predict treatment response....